Related Experiment Videos
Enkephalin-like character and analgesia
European Journal of Pharmacology
|January 29, 1981
Summary
Researchers studied opioid activities of enkephalin analogues. Enkephalin-like compounds may reduce analgesic effects when administered cerebroventricularly, hindering pain relief.
Area of Science:
- Pharmacology
- Neuroscience
- Medicinal Chemistry
Background:
- Enkephalins are endogenous opioid peptides with significant physiological roles.
- Analogs of enkephalins are explored for therapeutic potential, particularly in pain management.
- Understanding structure-activity relationships is crucial for developing effective opioid-based analgesics.
Purpose of the Study:
- To investigate the opioid activities of novel enkephalin analogues.
- To differentiate opioid receptor interactions of these analogues in vitro.
- To correlate in vitro opioid profiles with in vivo analgesic efficacy.
Main Methods:
- In vitro assays using guinea-pig ileum and mouse vas deferens preparations.
- In vivo analgesic testing using the rat tail-flick test.
- Synthesis and characterization of enkephalin analogues with D-/L-aminopentane-sulfonic/phosphonic acid substitutions.
Main Results:
- Enkephalin analogues exhibited varied opioid activities, including Met-enkephalin-like, beta-endorphin-like, and (nor)morphine-like profiles.
- Compounds with intermediate opioid characteristics were also identified.
- A correlation was observed between in vitro opioid activity and in vivo analgesic effects.
Conclusions:
- The enkephalin-like character of pentapeptides may impede analgesic activity expression.
- Cerebroventricular administration of certain enkephalin analogues might hinder central analgesic effects.
- These findings offer insights into the design of opioid-based analgesics with improved efficacy.